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Abstract
Background: In addition to breast imaging, ultrasound offers the potential for characterizing and distinguishing
between benign and malignant breast tissues due to their different microstructures and material properties. The
aim of this study was to determine if high-frequency ultrasound (20-80 MHz) can provide pathology sensitive
measurements for the ex vivo detection of cancer in margins during breast conservation surgery.
Methods: Ultrasonic tests were performed on resected margins and other tissues obtained from 17 patients,
resulting in 34 specimens that were classified into 15 pathology categories. Pulse-echo and through-transmission
measurements were acquired from a total of 57 sites on the specimens using two single-element 50-MHz
transducers. Ultrasonic attenuation and sound speed were obtained from time-domain waveforms. The waveforms
were further processed with fast Fourier transforms to provide ultrasonic spectra and cepstra. The ultrasonic
measurements and pathology types were analyzed for correlations. The specimens were additionally re-classified
into five pathology types to determine specificity and sensitivity values.
Results: The density of peaks in the ultrasonic spectra, a measure of spectral structure, showed significantly higher
values for carcinomas and precancerous pathologies such as atypical ductal hyperplasia than for normal tissue. The
slopes of the cepstra for non-malignant pathologies displayed significantly greater values that differentiated them
from the normal and malignant tissues. The attenuation coefficients were sensitive to fat necrosis, fibroadenoma,
and invasive lobular carcinoma. Specificities and sensitivities for differentiating pathologies from normal tissue were
100% and 86% for lobular carcinomas, 100% and 74% for ductal carcinomas, 80% and 82% for benign pathologies,
and 80% and 100% for fat necrosis and adenomas. Specificities and sensitivities were also determined for
differentiating each pathology type from the other four using a multivariate analysis. The results yielded specificities
and sensitivities of 85% and 86% for lobular carcinomas, 85% and 74% for ductal carcinomas, 100% and 61% for
benign pathologies, 84% and 100% for fat necrosis and adenomas, and 98% and 80% for normal tissue.
Conclusions: Results from high-frequency ultrasonic measurements of human breast tissue specimens indicate
that characteristics in the ultrasonic attenuation, spectra, and cepstra can be used to differentiate between normal,
benign, and malignant breast pathologies.
Background
In breast conservation surgery (BCS), obtaining negative
(cancer free) margins is critically important for local
control of breast cancer in the treated breast [1,2]. Con-
sequently, failure to obtain negative margins during the
initial surgery results in re-excision for 30-50% of
patients [1-5]. A recent study of 994 women diagnosed
with ductal carcinoma in situ (DCIS) showed that both
treatment strategy (BCS alone, BCS with radiation ther-
apy, or mastectomy) and margin status strongly corre-
lated with long-term ipsilateral disease-free survival, but
that positive or close margins following the last surgical
treatment significantly reduced 5-year and 10-year
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any medium, provided the original work is properly cited.ipsilateral event-free survival independent of treatment
strategy [6].
Several approaches are therefore being investigated for
the pre-operative and intraoperative estimation of mar-
gin sizes as well as for the intraoperative detection of
cancer in surgical margins. Methods studied for the esti-
mation of margin sizes include pre-operative CT and
MRI and intraoperative ultrasonic imaging with conven-
tional medical ultrasound instrumentation [4,7,8]. A
number of electromagnetic and optical methods are also
being developed for the intraoperative detection of can-
cer in margins. These include terahertz imaging [9],
Raman spectroscopy [10], optical coherence tomography
[11], and diffuse reflectance spectroscopy [12]. Intrao-
perative pathology methods currently being used for
margin assessments include touch preparation cytology
and frozen section analyses. These methods have limita-
tions, however, including the requirement for an on-site
trained pathologist, the inability to identify close mar-
gins (touch preparation cytology), and the ability to
sample only a small portion of the margin (frozen sec-
tion analyses) [12].
Many studies have shown that ultrasonic wave propa-
gation in tissues is strongly dependent on histological
features including cell structure, cell number density,
tissue microstructure, and tissue heterogeneity [13-24].
Ultrasound therefore presents the potential of being able
to differentiate between normal, benign, and malignant
pathologies in breast tissue [25,26]. Of specific relevance
to margin assessments was a study performed on eight
mastectomy specimens using ultrasound transmission
tomography from 2-10 MHz [27]. The frequency depen-
dent attenuation was used to classify regions of each
specimen into three types of tissue: Normal, benign
changes, and invasive carcinoma. The high spatial reso-
lution of the scans (≤ 1 mm) permitted a high degree of
correlation to pathology micrographs, and yielded an
80% sensitivity, 90% specificity, and 86% accuracy for
the three-way classification method.
High-frequency (HF) ultrasound has also been shown
to be sensitive to changes in cell and tissue histology
associated with mouse mammary tumors [22], apoptosis
of malignant cells in centrifuged and dilute cell suspen-
sions in vitro [28-30], apoptosis of malignant cells in rat
tissues ex vivo and in vivo [31], and apoptosis in mouse
tumors following photodynamic and radiation therapies
[32,33]. Normal and malignant human breast epithelial
cells have additionally been differentiated in vitro in
monolayer cell cultures using 20-50 MHz ultrasound
[34], and tumor size and margin status in 2-5 mm thick
ductal carcinoma specimens have been determined with
15-50 MHz scanning acoustic microscopy [35].
In addition to experimental measurements, numerical
models of ultrasonic wave propagation at the
microstructural level have shown that HF ultrasound
may be sensitive to tissue pathology [34,36-38]. Experi-
mental studies using normal and malignant monolayer
cultures of human breast epithelial cells as well as
mouse liver specimens have validated the modeling
approaches [34,38].
The objective of this study was to determine if HF
ultrasound (20-80 MHz) could provide pathology sensi-
tive measurements for the ex vivo detection of cancer in
surgical margins obtained during breast conservation
surgery. Both pulse-echo and through-transmission mea-
surements were performed on the breast tissue speci-
mens. The data analysis included examining
conventional ultrasonic parameters such as ultrasonic
sound speed and attenuation for correlations to pathol-
ogy, as well as developing new approaches to analyze
ultrasonic spectra and cepstra.
Methods
A HF ultrasonic test system, Figure 1a, was developed to
collect simultaneous pulse-echo and through-transmis-
sion measurements from margins and other tissue speci-
mens following resection from BCS. The data were
analyzed with a variety of methods to search for correla-
tions to tissue pathology.
Clinical protocol
The ultrasonic testing of tissue specimens obtained dur-
ing the course of routine breast conservation surgery
was approved by the University of Utah Institutional
Review Board on October 14, 2009, as a minimal risk
study (IRB #00037350). Informed consent was obtained
from patients for the use of their tissues for research
purposes. Surgeries were performed on 17 patients by
the collaborating surgeon and coauthor (LAN) at the
Huntsman Cancer Hospital, Salt Lake City, Utah. The
surgeries provided 34 resected specimens consisting of
margins and other tissues such as lymph nodes and ade-
nomas. The samples ranged from 1-5 cm in length and
width, 0.1-1.5 cm in thickness, comprised a spectrum of
both benign and malignant tissue pathologies, and did
not require any additional procedures or resection that
affected the patient or surgical outcome. Table 1 lists
the range of pathologies provided by the specimens. For
the purposes of this study the pathologies were categor-
ized into 15 classifications. Immediately following resec-
tion, the surgeon placed each specimen inside a re-
sealable plastic storage bag for ultrasonic testing (Figure
1b), and labeled the bag with a de-identified specimen
number and, if applicable, the orientation of the margin.
During the ultrasonic testing, the outside of the bag
was coupled to the ultrasonic transducers with ultra-
sound scanning gel (Sonotech
® Clear Image). The sur-
face moisture of the tissue provided sufficient coupling
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transmission. The bag therefore prevented contamina-
tion of the specimen with coupling fluid and additionally
provided improved transmission of ultrasound between
the transducers and specimen. One to four sites were
tested on each specimen depending on the specimen
size, resulting in a total of 57 sites tested. Triplicate
waveforms were acquired from each test site on a speci-
men. After ultrasonic testing, routine pathology analyses
were performed on the specimens. Ultrasonic results
were correlated to pathology reports for each specimen.
Ultrasonic materials and procedure
Ultrasonic pulse-echo and through-transmission data
were acquired from breast tissue specimens with the use
of two immersion transducers (Olympus NDT, V358-SU,
50 MHz, 0.635-cm diameter active element), a HF
square-wave pulser/receiver (UTEX, UT340), and a digi-
tal storage oscilloscope (Hewlett-Packard, HP-54522A,
500 MHz, 1Gs/s). Ultrasonic waveforms were averaged in
the signal acquisition and downloaded onto a notebook
PC using LabVIEW. The data acquisition parameters
were pulse voltage = 100 V, pulse width = 10 ns, pulse
repetition rate = 5 kHz, and receiver gain = 0-48 dB. An
aluminum test fixture, Figure 2a, was used to support the
tissue specimen, to position the transducers both above
and below the sample for simultaneous pulse-echo and
through-transmission measurements, and to lock the
transducers into position. The thickness of the specimen
was recorded for each ultrasonic measurement. A
description was also recorded for each specimen, and
photographs were taken of 19 specimens (e.g., Figure 1b).
The ultrasonic transducers each had a center frequency
of 50 MHz and were broadband, providing a short pulse
length and enhanced signal-to-noise in highly scattering
or attenuating materials. The broadband characteristics
of the transducers were also desired to obtain the ultraso-
nic response of the tissue across a wide frequency band.
Ultrasonic data analysis
The HF ultrasonic signals acquired in this study were
substantially different from the typical ultrasonic signals
Figure 1 Photograph of aluminum test fixture with instrumentation (a) and surgical margin in plastic re-sealable bag (b).
Table 1 Pathology, number of specimens, and number of
positions tested with high-frequency ultrasound
Tissue type Specimens No. of test
positions
Lymph nodes (LN) 3 2
Benign or normal breast (BB) 4 5
Benign breast with calcifications
(BC)
23
Atypical ductal hyperplasia (ADH) 2 5
Fibrocystic change (FC) 2 6
Fat necrosis (FN) 1 1
Fibroadenoma (FA) 2 2
Tubular adenoma (TA) 1 1
Papilloma (PA) 4 4
Total benign 21 29
Ductal carcinoma in situ (DCIS) 3 6
DCIS, solid and cribriform (DCIS-SC) 2 3
DCIS + IDC 3 9
Invasive ductal carcinoma (IDC) 2 3
Lobular carcinoma in situ (LCIS) 2 4
Invasive lobular carcinoma (ILC) 1 3
Total Malignant 13 28
Acronyms in parentheses are used in subsequent figures.
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sue characterization. Whereas typical medical ultrasound
signals are comprised of scattered waves from dispersed
scattering centers, typically cells or nuclei, and other tis-
sue inhomogeneities such as blood vessel walls, the sig-
nals collected in this study were of the transmitted pulse
after propagating through the tissue specimen (through-
transmission mode, Figure 2b) or of the specular reflec-
tion of the transmitted pulse from the surface of the
second transducer (pulse-echo mode, Figure 2c). There-
fore, in contrast to most medical ultrasound signals, the
signals in this study had pulse-like characteristics with
amplitudes significantly greater than background noise.
For through-transmission measurements, Figure 2b,
the ultrasonic data consisted of time-domain waveforms
of ultrasonic pulses, Figure 3a, that were transmitted
from the top transducer, passed through the specimen
only once, and received by the bottom transducer. For
the pulse-echo measurements, Figure 2c, the ultrasonic
data consisted of time-domain waveforms of ultrasonic
pulses, Figure 3b, that were transmitted from the top
transducer, passed through the specimen, reflected from
the surface of the bottom transducer, passed through
the specimen a second time, and received by the top
transducer. The ultrasonic signals for both modes of
operation therefore provided a convolution of the trans-
ducer and tissue responses.
Tumor progression and other atypical conditions
affect the acoustic properties of tissues by altering the
cell properties, the extracellular matrix properties, and
the tissue microstructure. Measurement of sound speed
and attenuation can therefore be used to reveal benign,
pre-cancerous, or malignant tissues in breasts [25-27].
For calculation of ultrasonic sound speeds and attenua-
tion coefficients, the arrival times and amplitudes of the
time-domain waveforms were determined using a Hil-
bert transform. Arrival times were calibrated using a
P l e x i g l a sb l o c ka sas u b s t i t u t ef o rt h et i s s u es a m p l e s .
Attenuation coefficients were based on a relative scale
by setting the lowest calculated attenuation value for the
specimens (a fibroadenoma) to 0.003 Nepers/cm.
Attenuation calculations accounted for receiver gain and
specimen thickness.
The ultrasonic data were additionally analyzed in the
frequency domain since previous numerical studies had
indicated that the structure of HF ultrasonic spectra
should be sensitive to neoplastic changes in breast tis-
sues. Frequency spectra of the signals, Figures 4a and
4b, were obtained by subtracting background waveforms
from the tissue waveforms, windowing the main signals
in the waveforms, padding the waveforms to 4000 points
to increase the spectral resolution, and performing a fast
Fourier transform (FFT). The power spectra were then
derived by taking the absolute value of the complex
spectra. Analysis of the spectra included correlating spe-
cific spectral features, centroid frequencies of peak clus-
ters, and the density of peaks and valleys. The density of
peaks and valleys of a spectrum, from hereon referred
to as the density of peaks or peak density, was calcu-
lated by counting the number of zero crossings of the
derivative of the spectrum in the 20-80 MHz band.
The cepstrum is the inverse Fourier transform of the
log power spectrum, and has been used to provide the
mean scatterer spacing from ultrasonic data [20,39-41].
Applications have included measuring tibial cortical
thickness and the location of brachytherapy seeds in
Figure 2 Aluminum test fixture (a) and operation modes (b-c) used to position specimens and collect ultrasonic measurements. In the
pulse-echo mode (c), the receive transducer functions as a specular reflection surface for the ultrasonic waves.
Doyle et al. BMC Cancer 2011, 11:444
http://www.biomedcentral.com/1471-2407/11/444
Page 4 of 15tissue [40,41]. The cepstrum has also been used to
obtain the mean scatterer spacing for breast tissue clas-
sified as benign, simple carcinoma, infiltrating papillary
carcinoma, and fibroadenoma [20]. However, the low
spectral range, 0-10 MHz, limited the measurement of
scatterer spacings to greater than 0.15 mm, and the
measured mean scatterer spacing varied from 0.82 ±
0.10 mm for normal breast tissue to 1.25 ± 21 mm for
simple carcinoma.
The cepstra of waveforms were calculated in this
study by computing the spectrum from the unpadded
waveform, computing the inverse FFT of the log power
spectrum, and then taking the absolute value of the
resulting complex function. A modified cepstrum was
also used in this study to analyze data. Computation of
t h em o d i f i e dc e p s t r u mi n v o l v e du s i n gt h ep o w e rs p e c -
trum derived from the padded waveform, and were
obtained by windowing the power spectrum from 0 to
62.5 MHz, re-padding the spectrum to 4000 points, per-
forming a second forward FFT on the padded spectrum,
taking the absolute value of the complex function, and
normalizing the curves. The results produced modified
cepstra that showed a maximum at 0 μs and that sloped
Figure 3 Ultrasonic waveforms from through-transmission (a)
and pulse-echo (b) measurements of surgical tissue specimens.
Amplitudes have been normalized and offset for comparison. Figure 4 Ultrasonic spectra from through-transmission (a) and
pulse-echo (b) measurements of surgical tissue specimens.
Amplitudes have been normalized and offset for comparison. Note
the increase in spectral structure (peaks and valleys) from FA to
normal to LCIS, representing an increase in the ultrasonic parameter
peak density.
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Page 5 of 15downward with multiple peaks at various positions. The
modified cepstra were analyzed by calculating the slope
of the log of the modified cepstrum, which was approxi-
mately linear in the 0-0.3 μsr a n g e .T h ev a l u eo ft h e
modified cepstrum at 0.3 μs was also calculated. The
i n t e r c e p ta t0 . 3μs was chosen as a measurement para-
meter due to the change in slope of the modified cep-
strum at this point in the curve.
The data were evaluated with bar charts using the
median for the bar height and the median absolute
deviation (MAD) of the analyzed parameters for the
error bars. After analyzing the data by the 15 pathol-
ogy types as shown in Table 1, the data were reclassi-
fied into 5 pathology types: (1) normal breast tissue,
(2) FN-FA-TA (fat necrosis, fibroadenoma, and tubular
adenoma), (3) benign pathologies (BC, ADH, FC, and
PA), (4) ductal carcinomas (DCIS, DCIS-SC, DCIS +
IDC, and IDC), and (5) lobular carcinomas (LCIS and
ILC). These categories were used to assess the efficacy
of the preliminary measurements in this study for dif-
ferentiating carcinoma in resected margins. Specifici-
ties and sensitivities for pathology types (2)-(5) were
calculated with respect to normal tissue (1). Specifici-
ties and sensitivities for the five pathology types were
additionally determined using a two-parameter multi-
variate analysis. Finally, t-tests and one-way ANOVA
tests were performed to evaluate the significance level
of the results.
Results
Sound speed and attenuation measurements
The ultrasonic sound speed measurements were widely
scattered and displayed large deviations, rendering a dif-
ferentiation of pathology types difficult. Since the time
measurements were accurate to 1 ns (through-transmis-
sion) and 2 ns (pulse-echo), the principal cause for the
sound speed variations was the error in the thickness
measurements, which were performed manually by mea-
suring the displacement of the search tube that held the
top transducer from the test fixture. The error in this
measurement was ± 0.5 mm, providing sound speed
errors from 3.3% for the thickest samples (15.5 mm) to
42% for the thinnest samples (1.2 mm). Since the mean
sample thickness was 5.0 mm, the average error in
thickness and sound speed would be ± 10%. For glandu-
lar breast tissue, this error would translate to a sound
speed measurement of approximately 1.52 ± 0.15 mm/
μs[ 2 5 , 4 2 ] .S i n c et h eu l t r a s o n i cv e l o c i t i e so fb r e a s tf a t ,
cysts, and tumors lie within this range (1.46, 1.57, and
1.55 mm/μs, respectively) [25], it would be difficult to
differentiate between different breast pathologies with
sound speed measurements from this study.
T h eu l t r a s o n i ca t t e n u a t i o nmeasurements were prone
to similar large variations since the attenuation coeffi-
cient is inversely proportional to the thickness. Figure 5
displays the attenuation coefficients for the through-
transmission data. As shown in Figure 5, the attenuation
Figure 5 Attenuation coefficients from through-transmission data of tissue specimens, classified by pathology type.
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within the median absolute deviation range for the nor-
mal breast tissue (gray band). The exceptions are (1) fat
necrosis and fibroadenoma, which fall below the gray
band, (2) DCIS + IDC, which lies immediately above the
gray band, and (3) ILC, with an attenuation substantially
higher than all of the other pathologies and without
overlapping deviations. These results are consistent with
published data, which show lower attenuations for fat
and cysts as compared to glandular breast tissue and
considerably higher attenuations for tumors [25,42]. The
attenuation coefficients for the pulse-echo data were less
accurate due to the double pass of the wave through the
sample and plastic bag, giving rise to additional reflec-
tion losses.
Spectrum analysis
The ultrasonic spectra displayed a wide variation in
structure that roughly corresponded to pathology.
Although no single peak or group of peaks were found
that could be used to differentiate tissue type, the total
number of peaks and valleys in a specified spectral band
appeared to be dependent on tissue pathology. Figure 6
shows the density of peaks and valleys for the 20-80
MHz spectral band for the through-transmission data.
The peak density trends indicate that a majority of the
carcinoma pathologies are above the median absolute
deviation range for normal breast tissue (gray band),
with ILC displaying the highest peak densities. The
benign breast with calcifications and ADH classifications
also show significant separation from the normal breast
range, whereas the fat necrosis and adenoma specimens
lie below the gray band. Pathologies involving intraduc-
tal or intralobular changes therefore show elevated peak
densities, whereas those involving stromal proliferation
(adenomas) or fat necrosis show decreased peak densi-
ties. The peak densities in the 0-50 MHz band showed
similar trends as the 20-80 MHz band, but with greater
deviations. The peak densities from the pulse-echo data
displayed less consistent trends that were less useful at
distinguishing between different pathology types.
Cepstrum analysis
A cepstrum analysis of the pulse-echo data showed that
several of the samples produced multiple peaks across a
range of mean scatterer spacings d = ct/2, where d is
the spacing between scatterers, c is the tissue sound
speed, and t i st h et i m eo ft h ep e a ki nt h ec e p s t r u m
[39]. Most of the peaks occurred in an apparently ran-
d o mf a s h i o na n dc o u l dn o tb ec o r r e l a t e dt op a t h o l o g y .
However, one peak at t = 0.102 μs( d =7 7μm) occurred
prominently in 10 of the 15 pathology types, but was
absent in lymph node, fibroadenoma, tubular adenoma,
DCIS + IDC, and LCIS tissues. In the 10 pathology
types where the peak was present, the amplitude of the
peak varied significantly from specimen to specimen,
and it therefore could not be used to discriminate
between the 10 pathology classifications. A secondary
peak at t = 0.2 μs was additionally present whenever the
0.102-μs peak was observed, indicating that the 0.2-μs
Figure 6 Peak densities in the 20-80 MHz band of through-transmission spectra from tissue specimens.
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Page 7 of 15peak was due to either a multiple wave reflection or a
multiple of the mean scatterer spacing.
Since the slopes of the modified cepstra from 0 to 0.3 μs
were negative, the absolute values of the slopes are dis-
played in Figure 7 for comparison of trends. Intraductal
papilloma displayed essentially the same slope and deviation
values as normal breast tissue. The carcinomas displayed
slopes above the median absolute deviation range for nor-
mal breast tissue (gray band), but their large deviations indi-
cated poor separation from the normal breast tissue values.
However, the other seven benign pathologies and tissues
displayed significantly greater slopes than normal breast tis-
sue, with values and deviations well above the normal breast
tissue range. Fat necrosis, fibroadenoma, and tubular ade-
noma displayed the greatest slopes. The modified cepstrum
values at 0.3 μs produced trends similar to the slopes.
Results for re-categorized pathology types
By reclassifying the breast pathologies into five groups,
the efficacy of the analysis parameters and high-fre-
quency ultrasonic data used in this study were assessed
for the detection of carcinoma in resected margins. The
reclassified pathology types w e r e( 1 )n o r m a lb r e a s tt i s -
sue, (2) fat necrosis/fibroadenoma/tubular adenoma
(FN-FA-TA), (3) benign pathologies, (4) ductal carcino-
mas (DCIS and IDC), and (5) lobular carcinomas (LCIS
and ILC). Figures 8, 9, and 10 show the attenuation
coefficients, peak densities, and cepstral slopes, respec-
tively, for the reclassified pathology types.
Table 2 displays a preliminary analysis of the data
shown in Figures 8, 9, and 10 using binary classification
tests to yield the specificity and sensitivity of each tissue
category as compared to normal breast tissue. The spe-
cificity and sensitivity values were calculated directly
from the measured data. The mean of the median values
was used as the classification threshold between each
tissue category and normal tissue. The peak density
Figure 7 Modified cepstrum slopes from pulse-echo data of tissue specimens, classified by pathology type.
Figure 8 Attenuation coefficients for the reclassified tissue
specimens.
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nant tissues, whereas the cepstrum slope provided the
highest values between normal tissue and benign pathol-
ogies. Both peak density and cepstrum slope gave the
same values between normal and FN-FA-TA patholo-
gies. The binary classification tests indicated higher spe-
cificities and sensitivities for lobular carcinomas than for
ductal carcinomas. The specificities and sensitivities are
expected to improve with more measurements from
future studies.
The significance of the specificities and sensitivities in
Table 2 were analyzed with t-tests. Table 3 displays the
t-test and p-value for each of the four pathology groups
in comparison to normal tissue, and for each of the
three ultrasonic parameters. The analyses that provided
statistically significant values (p < 0.05) were peak den-
sity for lobular carcinomas, ductal carcinomas, and FN-
FA-TA pathologies, and cepstrum slope for FN-FA-TA
and benign pathologies. All five pathology groups were
additionally analyzed with one-way ANOVA tests to
determine which of the three ultrasonic parameters pro-
vided statistically significant separation of all five groups.
The F-ratio for attenuation was F4, 31 = 3.933, indicating
that the results are significant at the 5% level and very
close to the 1% level of significance. Similarly, the F-
ratio for peak density was F4, 31 = 3.728, again indicating
that the results are significant at the 5% level and close
to the 1% level of significance. Finally, the F-ratio for
cepstrum slope was F4, 25 = 1.854, indicating that the
results are not significant at the 10% level. Therefore, in
contrast to the paired t-tests, the ANOVA tests suggest
that attenuation and peak density provide the highest
significance for distinguishing between the pathology
types.
A multivariate analysis was also performed on the re-
categorized data by using the two-dimensional para-
meter space defined by attenuation and peak density
(Figure 11a). Classification boundaries were determined
in this space by rotating and translating the coordinates
of the data points and calculating linear and parabolic
Figure 9 Peak densities in the 20-80 MHz band for the
reclassified tissue specimens.
Figure 10 Modified cepstrum slopes for the reclassified tissue
specimens.
Table 2 Highest specificity and sensitivity values from
analysis of data classified into five pathology categories
Pathology Parameter Specificity Sensitivity
Lobular
carcinomas
Peak density 100% 86%
Ductal
carcinomas
Peak density 100% 74%
FN-FA-TA Peak density & cepstrum
slope
80% 100%
Benign
pathologies
Cepstrum slope 80% 82%
The specificity and sensitivity for each tissue category was calculated with
respect to normal breast tissue.
Table 3 t-test results from analysis of data classified into
five pathology categories
Pathology Attenuation Peak density Cepstrum slope
Lobular carcinomas t(10) = 2.14
p < 0.10
t(10) = 2.952
p < 0.02
t(10) = 0.88
p > 0.20
Ductal carcinomas t(22) = 1.305
p > 0.20
t(22) = 2.233
p < 0.05
t(19) = 1.406
p < 0.20
FN-FA-TA t(7) = 1.278
p > 0.20
t(7) = 2.609
p < 0.05
t(7) = 4.615
p < 0.01
Benign pathologies t(21) = 1.414
p < 0.20
t(21) = 1.751
p < 0.10
t(20) = 2.883
p < 0.01
The t-test and p-value for each tissue category was calculated with respect to
normal breast tissue.
Doyle et al. BMC Cancer 2011, 11:444
http://www.biomedcentral.com/1471-2407/11/444
Page 9 of 15boundaries that maximized inclusion of a pathology
category and exclusion of the other four categories (Fig-
ure 11b). The one exception was for ductal and lobular
carcinomas, which were intimately mixed and therefore
difficult to separate in this first-look analysis. Specifici-
ties and sensitivities for each of the five pathology types,
Table 4, were then calculated with respect to all of the
other pathology types that were excluded by the bound-
ary. The multivariate analysis shows that the ultrasonic
measurements have good specificity and sensitivity for
carcinomas with respect to all benign conditions (nor-
mal breast tissue, benign pathologies, and FN-FA-TA).
The sensitivities for the carcinomas and FN-FA-TA
pathologies remained the same in the multivariate analy-
sis, whereas the specificities for the FN-FA-TA and
benign pathologies increased. Values that decreased in
the multivariate analysis included the specificities for the
carcinomas and the sensitivity for the benign
pathologies. Although some of the values in Table 4 are
lower than those in Table 2, this is to be expected since
Table 2 reports values for detecting and differentiating a
particular pathology from only normal tissue, whereas
Table 4 reports values for detecting and differentiating a
particular pathology from all other studied pathology
types. The overlap between pathology categories is
therefore more evident in the multivariate analysis, and
c o n s e q u e n t l yt h er e s u l t si nT a b l e4a r em o r er e a l i s t i c
for distinguishing between pathologies such as ductal
carcinoma and benign pathologies (e.g., ADH or fibro-
cystic changes).
The specificity and sensitivity results from this study
(Tables 2 and 4) are comparable to those for various
methods currently in use or under development for
intraoperative margin assessments. Table 5 summarizes
the reported specificity and sensitivity values for several
of these methods. Since the values in Table 5 are pri-
marily for malignant versus normal breast tissue, they
are comparable most properly to the values in Table 2.
A principal advantage of the HF ultrasonic method
reported in this study over several of the methods listed
in Table 5 is its ability to differentiate across a wider
class of breast pathologies, including benign conditions
and fat necrosis-adenomas. The ability to differentiate
between different types of breast pathology, including
different types of breast cancer, would be a significant
advantage for an intraoperative margin assessment
method. Of particular importance would be the
Figure 11 Multivariate analysis of peak density and attenuation parameters in ultrasonic data. (a) Non-rotated plot of attenuation vs.
peak density. (b) Rotated and translated plot of attenuation vs. peak density, showing the use of parabolic and linear curves for the classification
boundaries. F = fat necrosis - fibroadenoma - tubular adenoma. B = benign pathology. N = normal breast tissue. M = malignant breast tissue.
Table 4 Multivariate analysis results
Pathology Specificity Sensitivity
Lobular carcinomas 85% 86%
Ductal carcinomas 85% 74%
FN-FA-TA 84% 100%
Benign pathologies 100% 61%
Normal tissue 98% 80%
The specificity and sensitivity for each tissue category was calculated with
respect to a five-way classification system using the classification boundaries
as defined in Figure 11.
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ADH and fibrocystic changes from malignancies.
Although a basic multivariate analysis of our preliminary
data does not yet provide high enough sensitivities and
specificities (> 70%) for clinically relevant detection and
differentiation of all five pathology categories (specifi-
cally for benign pathologies), refinement of the measure-
ment technique and multivariate analyses of larger,
more comprehensive data sets may improve these cap-
abilities. They may also provide further diagnostic cap-
abilities for a more highly resolved classification system
such as shown in Table 1 and Figures 5, 6, and 7.
The strong response of HF ultrasound to lobular car-
cinomas (Table 2 and Figures 5, 6, 8, and 9) may addi-
tionally provide an accurate and clinically important
method to detect ILC in surgical margins. Negative mar-
gins are difficult to achieve for ILC with conventional
BCS. Six studies published between 1994 and 2006
reported 49-63% positive or close margins following the
initial surgery, and a recent study reported the use of
full thickness excision and oncoplastic surgery to lower
the rate of positive/close margins to 39% [43]. Taken as
a pathology classification by itself, the findings of our
study show that ILC is particularly easy to detect and
identify as compared to other carcinomas and patholo-
gies. Both peak density and attenuation provide specifi-
city and sensitivity values of 100% for differentiating ILC
from normal breast tissue. Attenuation also has 100%
specificity and sensitivity for differentiating ILC from
benign pathologies, whereas peak density has 83% speci-
ficity and 67% sensitivity.
Discussion
Correlation of results and microstructural interpretations
Contrary to previous results from numerical models
[36,37], no single peak or feature could be identified in
the experimental spectra that correlated to pathology
type and could therefore be used as a predictor for tis-
sue microstructure. One parameter, however, that corre-
lated with both benign and malignant changes to the
mammary ducts was the spectral density of peaks.
Pathologies that would result in enlargement of the duct
or growth of a solid mass within the duct produced
greater peak densities than normal breast tissue. Such
pathologies included calcifications, ADH, intraductal
papilloma, and DCIS solid and cribriform. These results
appear to correlate strongly with the peak densities
from ultrasonic backscatter spectra from a layered cylin-
der model, where duct enlargement or neoplasm growth
in the lumen results in higher peak densities (Figure 12).
The layered cylinder model used multipole expansions
to simulate ultrasonic scattering from mammary ducts
represented as three-dimensional cylinders with an
epithelial cell layer and interior lumen, and was similar
to a model used to simulate elastic wave scattering from
normal and clotted blood vessels [44]. The observed
increases in peak density with the layered cylinder
model provide an interpretation of the experimental
data in terms of microstructural remodeling of the nor-
mal ductal architecture. Increases in ductal diameter,
wall thickness, and lumen composition (fluid, hyperplas-
tic, or malignant) have a direct and significant affect on
the peak densities.
A microstructural interpretation for the slope of the
modified cepstrum is that the slope would be a measure
of the distribution of scatterer spacings between 0 and
225 μm, with a large slope indicating a distribution
skewed to small spacings, and a small slope indicating a
distribution skewed to large spacings. The interpretation
for the 0.3-μs intercept would be similar. Since the cep-
stra were normalized and had negative slopes, a high
intercept value would indicate a shallow (small) slope
and large scatterer spacings. Conversely, a low intercept
value would indicate a steep (large) slope and small
scatterer spacings. Figure 7 reveals that the slopes for
the modified cepstra displayed significant differences for
seven of the benign pathology types as compared to the
normal breast tissue and carcinoma pathologies.
At first the cepstral results appear inconsistent with a
histological interpretation. Ductal dilation, thickening,
and hyperplasia are characteristic of several benign
pathologies including calcifications, ADH, and fibrocys-
tic changes. These changes are expected to increase the
mean spacing of the scatterers, yet the cepstral results
for the ultrasonic measurements indicate that the mean
scatterer spacings are less for the benign pathologies.
An alternative explanation, however, is that the expan-
sion arising from ductal dilation will decrease the inter-
ductal spacings in the tissue. This interpretation
attributes the mean scatter spacing, as measured by the
modified cepstrums l o p ea n d0 . 3 - μs intercept, to the
distances between neighboring ducts. This interpretation
appears consistent with the experimental data. Further
simulation work with models containing multiple
Table 5 Specificity and sensitivity values for various
intraoperative margin assessment methods
Method and references Specificity Sensitivity
Touch preparation cytology [45,46] 83-100% 75-96%
Frozen section analysis [5,47,48] 92-100% 65-78%
Near-field RF spectroscopy [49] 70% 70%
Raman spectroscopy [50] 93% 83%
Optical coherence tomography [11] 82% 100%
Fluorescence and reflectance spectroscopy
[51]
96% 85%
Low-freq. (2-10 MHz) ultrasonic attenuation
[27]
90% 80%
Values represent comparison between normal vs. malignant tissue.
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material properties may provide a more complete corre-
lation of the cepstrum results to ductal architecture.
Differentiation of pathology categories
The results of this pilot study indicate that high-fre-
quency ultrasound can produce clinically relevant speci-
ficity and sensitivity values for detecting malignant
tissues in surgical margins and differentiating them from
normal tissue (Table 2) as well as from fat necroses,
fibroadenomas, and tubular adenomas (Table 4). The
sensitivity values for benign pathologies such as ADH,
benign calcifications, fibrocystic change, and papilloma
are low (< 70%), however, and are therefore not yet suf-
ficient for differentiating these tissues from malignant
tissues. These values may improve with a more rigorous
multivariate analysis of the parameters obtained in this
study from the ultrasonic waveform (attenuation), spec-
trum (peak density), and modified cepstrum (cepstral
slope).
A single ultrasonic parameter is often insufficient to
diagnose breast cancer in vivo,a n dm a n yr e s e a r c h e r s
are exploring multivariate methods to discriminate
between malignant and benign pathologies in methods
such as ultrasonic tomography [25,26]. Sound speed and
attenuation have been the two most widely used para-
meters to date to combine into a multivariate analysis.
The results of this study, however, indicate that attenua-
tion, spectral peak density, and modified cepstrum slope
may be complementary parameters for differentiating
various breast pathologies.
The peak density results (Figures 6 and 12) indicate
that disrupted ductal architectures produce higher peak
densities in selected frequency ranges as compared to
normal breast tissue. Exceptions to this correlation are
the fat necrosis and adenomas which show lower peak
densities than normal breast tissue and where ductal
structures are either absent or severely distorted, respec-
tively. Since both benign and malignant processes can
disrupt ductal microstructures, a second parameter is
required to differentiate between these two processes.
The slopes or 0.3-μs intercepts of the modified cepstra
(Figure 7) may provide this parameter by separating
most of the benign pathologies from normal breast tis-
sue and various carcinomas.
Origin of uncertainties
As already discussed, one source of uncertainty in the
experimental data was the measurement of tissue thick-
ness, which has the most significant impact on the mea-
surement of effective material properties such as sound
speed and attenuation. The other source of uncertainty
in the measurements was the correlation of the mea-
surement position on the specimen to the microscopic
extent of the pathology in the tissue. Although ultraso-
nic measurements were correlated to the orientation of
the margin, the diameter of the transducer elements
(0.635 cm), in addition to the lack of an exact point-by-
Figure 12 Simulated peak densities in the 20-80 MHz spectral band for a layered cylinder model. Model consisted of arbitrarily oriented
layered cylinders with a fluid-filled (benign or soft) or solid-filled (atypical or malignant) lumen.
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pathology in this study, most likely resulted in the sam-
pling of tissues of mixed pathologies (e.g., normal breast
plus DCIS) in a significant number of measurements.
This measurement uncertainty is most probably the
main source of the median absolute deviations in the
peak density and cepstrum plots (Figures 6 and 7).
Finally, the small number of tested samples in this pilot
study limits the statistical robustness of the results, par-
ticularly for pathology types with only one or two mea-
surements. Implementing a more comprehensive
experimental design in subsequent studies is therefore
essential to minimizing the thickness and positioning
errors as well as to increasing the number of measure-
ments for each pathology category.
Conclusions
High-frequency ultrasonic measurements were collected
from resected margins and other breast tissues. Attenua-
tion, spectral, and cepstral analyses of these measure-
ments show correlations to both benign and malignant
pathologies that could potentially be used in a multivari-
ate analysis to determine tissue pathology for intrao-
perative margin assessments. The density of peaks in
the ultrasonic spectra is a key parameter in the correla-
tions, and appears to be linked to the disruption of the
ductal architecture in breast tissue.
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